NewAmsterdam Pharma (NASDAQ:NAMS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NewAmsterdam Pharma (NAMS) operate in?

NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NewAmsterdam Pharma Stock (NASDAQ: NAMS) stock price, news, charts, stock research, profile.

Open	$25.68
Close	$25.96
Volume / Avg.	727.60K / 740.83K
Day Range	$25.50 - $26.80
52 Wk Range	11.03 - 27.29
Market Cap	$2.78B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	3.68%
Days to Cover	1.37

Recent News

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?

These 10 mid-cap stocks performed well last week. Are they in your portfolio? PDCO, NAMS, WBA, NVCR, RH, PTVE, CRK, RNW, ALK, STVN.

Lekha Gupta

Top 3 Health Care Stocks That May Collapse This Quarter

Avi Kapoor

Why Is NewAmsterdam Pharma Stock Trading Higher On Tuesday?

NewAmsterdam Pharma reports Phase 3 trial success for obicetrapib, achieving significant LDL-C reduction in ASCVD and HeFH patients on standard therapy.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul 24

Aug 24

Sep 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$25.68
Close	$25.96
Volume / Avg.	727.60K / 740.83K
Day Range	$25.50 - $26.80
52 Wk Range	11.03 - 27.29
Market Cap	$2.78B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	3.68%
Days to Cover	1.37

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NewAmsterdam Pharma (NAMS) stock?

You can purchase shares of NewAmsterdam Pharma (NASDAQ:NAMS) through any online brokerage.

View our list of the best stock brokerages

Who are NewAmsterdam Pharma (NAMS) competitors?

Other companies in NewAmsterdam Pharma’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for NewAmsterdam Pharma (NAMS) stock?

NewAmsterdam Pharma has a consensus price target of $32.67.

What is the current price for NewAmsterdam Pharma (NAMS)?

The stock price for NewAmsterdam Pharma (NASDAQ: NAMS) is $25.96 last updated January 2, 2025 at 4:00 PM EST.

Does NewAmsterdam Pharma (NAMS) pay a dividend?

There are no upcoming dividends for NewAmsterdam Pharma.

When is NewAmsterdam Pharma (NASDAQ:NAMS) reporting earnings?

NewAmsterdam Pharma’s Q4 earnings are confirmed for Thursday, February 6, 2025.

Is NewAmsterdam Pharma (NAMS) going to split?

There is no upcoming split for NewAmsterdam Pharma.

What sector and industry does NewAmsterdam Pharma (NAMS) operate in?

NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

NewAmsterdam Pharma

NewAmsterdam Pharma (NAMS) Forecast